Pfizer CEO pockets $33M for 2022 after 36% pay hike

Pharmaceutical Executives Testify At Senate Finance Committee Hearing On Drug Prices

Win McNamee

Pfizer (NYSE:PFE) Chief Executive and Chairman Albert Bourla will likely become one of the top-earning pharma CEOs for 2022 after the pharma giant took his total compensation to $33.0M handing him a ~36% pay hike for last year.


Business Asia
the authorBusiness Asia

Leave a Reply